16. Cervix cancer - The GEC-ESTRO Handbook of Brachytherapy

Cervix cancer

29

THE GEC ESTRO HANDBOOK OF BRACHYTHERAPY | Part II Clinical Practice Version 1 - 01/09/2023

Figure 29. EMBRACE-I bladder morbidity (physician assessed and patient reported): Correlation between urinary frequency and urinary incontinence and ICRU bladder point dose (Reprinted from Radiother. Oncol., 158, Spampinato S, Fokdal LU, Pötter R, et al., Importance of the ICRU bladder point dose on incidence and persistence of urinary frequency and incontinence in locally advanced cervical cancer: An EMBRACE analysis, 300-308, 2021, with permission from Elsevier).